Bicalutamide Market Analysis By Type (Tablets, Injectable Formulations, Capsule), By Application (Single Drug For Prostate Cancer, Combined Chemotherapy For Prostate Cancer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Clinics) and by Region: Global Forecast, 2024 - 2034

  • 2024-04-29
  • 221
  • Healthcare & Life Sciences

Market Overview

The Bicalutamide market is predicted to develop at a compound annual growth rate (CAGR) of 8.11% from 2024 to 2034, when it is projected to reach USD 4.52 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 1.92 Billion in 2024.


SOURCE: We Market Research

Belicutamide is a medication used to treat prostate cancer by blocking the function of male hormones like testosterone, which can promote the growth of cancer cells. The oral medication bicalutamide is often used in combination with other treatments, such as hormone therapy or surgery, for the treatment of prostate cancer. It functions as an anti-androgen, inhibiting the harmful effects of testosterone on cancerous cells. Off-label uses of belicutamide include regulating women's excessive hair growth. Beclomethasone must be taken exactly as directed by a healthcare provider due to potential side effects and drug interactions.

A number of factors are driving the bicalutamide market worldwide. The global rise in prostate cancer cases and the progress made in cancer therapies fuel the market for this drug. Prostate cancer incidence rises with age, which increases the need for efficient treatments like bicalutamide. Proactive screening programs and increased awareness help with early detection and treatment initiation, which drives market expansion. The market reach is increased by improved healthcare access in emerging nations. Innovation is propelled by ongoing research and development initiatives targeted at improving the safety and efficacy profiles of bicalutamide. Market expansion is also greatly aided by favorable reimbursement and regulatory approval policies. 

Market Scope

Report Attributes


Market Size in 2024

USD 1.92 Billion

Market Forecast in 2034

USD 4.52Billion

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Type, By Application, by Distribution Channel, by End User and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria


Bicalutamide Industry: Dynamics & Restrains

 Market opportunity:


We Market Research: Bicalutamide Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Bicalutamide Segmentation

Market- By Type Analysis

By Type, the Bicalutamide Market is Categories into Tablets, Injectable Formulations, Capsule. The Tablets segment accounts for the largest share of around 57% in 2024.

Tablets dominate the bicalutamide market due to its price, ease of manufacturing, precision in dosage monitoring, patient preference for oral administration, and convenience. These factors contribute to its widespread adoption by healthcare providers and patients undergoing prostate cancer treatment regimens.

The following segments are part of an in-depth analysis of the global Bicalutamide market:

Market Segments


By  Application

·         Single Drug for Prostate Cancer

·         Combined Chemotherapy For Prostate Cancer

By  Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

By  End User

·         Hospitals & Clinics

·         Ambulatory Surgical Centers

·         Specialty Clinics


Bicalutamide Industry: Regional Analysis

North America Market Forecast

North America dominate the Bicalutamide Market with the highest revenue generating market with share of more than 48%. North America leads the world in bicalutamide sales because to its robust healthcare system and high prostate cancer incidence. Prostate cancer screening being more well known, innovative treatment options, and favorable reimbursement policies are some of the driving forces behind the market's growth.

Europe Market Statistics

Europe is second largest region in Bicalutamide Market. Europe also accounts for a sizable portion of the bicalutamide market. A sizable patient base, an aging population, and continuous research and development efforts are the main factors driving the industry. The rise of the industry is facilitated by government initiatives that raise awareness of cancer and provide accessibility to healthcare.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Bicalutamide market during the forecast period. In the Asia Pacific region, growing healthcare spending, a rise in prostate cancer cases, and bettering healthcare infrastructure are driving this region's bicalutamide market's explosive expansion. China and India, two emerging economies, are major drivers of market expansion.

Key Market Players

The Bicalutamide Market is dominated by a few large companies, such as

·         AstraZeneca


·         Zeneca GmbH

·         Actavis Pharma

·         Sivem Pharmaceuticals

·         Sorres Pharma

·         Fresenius Kabi

·         ANI Pharmaceuticals

·         Accel Pharma

·         Other

1.      Global Bicalutamide Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Bicalutamide Market Scope and Market Estimation

1.2.1. Global Bicalutamide Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Bicalutamide Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Bicalutamide Market

1.3.2. Technology of Global Bicalutamide Market

1.3.3. Distribution Channel of Global Bicalutamide Market

1.3.4. Region of Global Bicalutamide Market

2.      Executive Summary

2.1.    Global Bicalutamide Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Bicalutamide Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Bicalutamide Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034

4.1.1. Tablets

4.1.2. Injectable Formulations

4.1.3. Capsule

5.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Single Drug for Prostate Cancer

5.1.2. Combined Chemotherapy for Prostate Cancer

6.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

7.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by END USER

7.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

7.1.1. Hospitals & Clinics

7.1.2. Ambulatory Surgical Centers

7.1.3. Specialty Clinics

8.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Bicalutamide Market: Estimates & Forecast Trend Analysis

9.1.    North America Bicalutamide Market Assessments & Key Findings

9.1.1. North America Bicalutamide Market Introduction

9.1.2. North America Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By TYPE   By Application   By Distribution Channel   By END USER   By Country     The U.S.     Canada     Mexico

10.  Europe Bicalutamide Market: Estimates & Forecast Trend Analysis

10.1.  Europe Bicalutamide Market Assessments & Key Findings

10.1.1.   Europe Bicalutamide Market Introduction

10.1.2.   Europe Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By TYPE    By Application    By Distribution Channel    By END USER    By Country Germany U.K. France Italy Spain Russia Rest of Europe

11.  Asia Pacific Bicalutamide Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Bicalutamide Market Introduction

11.1.2.   Asia Pacific Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By TYPE    By Application    By Distribution Channel    By END USER    By Country China Japan India Australia South Korea ASEAN Rest of Asia Pacific

12.  Middle East & Africa Bicalutamide Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Bicalutamide Market Introduction

12.1.2.   Middle East & Africa Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By TYPE    By Application    By Distribution Channel    By END USER    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

13.  South America Bicalutamide Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Bicalutamide Market Introduction

13.1.2.   South America Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By TYPE    By Application    By Distribution Channel    By END USER    By Country Brazil Argentina Colombia Rest of South America

14.  Competition Landscape

14.1.  Global Bicalutamide Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Bicalutamide Market Competition White Space Analysis, By Distribution Channel

14.3.  Global Bicalutamide Market Competition Heat Map Analysis, By Distribution Channel

14.4.  Global Bicalutamide Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     AstraZeneca

15.1.1.   Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 


15.3.      Zeneca GmbH

15.4.      Actavis Pharma

15.5.      Sivem Pharmaceuticals

15.6.      Sorres Pharma

15.7.      Fresenius Kabi

15.8.      ANI Pharmaceuticals

15.9.      Accel Pharma

15.10.  Others

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Bicalutamide Market in 2024?

Bicalutamide Market was valued at USD 1.92 Billion in 2024.

What is the growth rate for the Bicalutamide Market?

Bicalutamide Market size will increase at approximate CAGR of 8.11% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Bicalutamide Market Are AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals, Accel Pharma and Others.

Which region dominates the Bicalutamide Market?

North America dominates the market with an active share of 48%.


Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI